3rd Annual EHS in Biopharma Summit 2026

 

Returning to Boston in 2026, the 3rd Annual EHS in Biopharma Summit is the only industry-specific meeting on the East Coast dedicated to uniting Global, Corporate, Vice President and Director-level Environment, Health & Safety leaders across biotech, pharma, CROs and CDMOs.

As the biopharma industry continues its rapid expansion, driven by the rise of radiopharmaceuticals, antibody-drug conjugates, cell and gene therapies, and novel vaccines, EHS professionals are under mounting pressure to scale safety systems, mitigate new biological and chemical risks, and embed sustainability into operations. This year’s meeting provides the strategic foresight and technical depth needed to support this transformation, ensuring zero serious injuries and fatalities in increasingly complex R&D and manufacturing settings.

Join 100+ senior EHS decision-makers from Sanofi, AbbVie, Biogen, AstraZeneca, Charles River Laboratories, Novartis, Jackson Laboratories, Ultragenyx, Genentech, and more to connect, collaborate, and benchmark your strategies against industry leaders tackling the same challenges.

More Info

---

---